Fig. 5From: Aging and the impact of global DNA methylation, telomere shortening, and total oxidative status on sarcopenia and frailty syndromeComparison of relative telomere length between patients with sarcopenia, frailty syndrome, healthy subjects above 50 years old (50 +) and healthy subjects at age 25–30 years old (25–30) in comparison to geriatrics control. Geriatric control was taken as 1. *p < 0.05 as statistically significantBack to article page